Introduction: Because of the complex physiopathology spasticity, it is distinguished as one most significant positive clinical signs upper motor neuron syndrome, constituting a feature that has great impact in neurorehabilitation setting. Thus, current study aimed to determine prevalence, onset, evolution, and prediction spasticity after stroke. Materials Methods: A correlational, longitudinal ...

BACKGROUND A cross-sectional study was performed to describe the upper limb deformity and function in cerebral palsy patients and to determine the correlation of deformity, spasticity, motor control, and sensation to hand function in the said population. MATERIALS AND METHODS Thirty patients satisfying our inclusion criteria underwent physical, sensory, and functional assessment using a stand...

[Purpose] Lower-limb spasticity after stroke may be associated with worse functional outcome. Our study aim was to establish whether a low-dose botulinum toxin A (BTX-A) injection in subacute stroke patients can improve spasticity, gait, and daily living abilities. [Subjects] Twenty-three subacute stroke patients were randomly allocated to BTX-A treatment group (11 patients) and control group (...

The clinical assessment of spasticity in stroke patients generally includes descriptive scales, such as the Modified Ashworth Scale (MAS) and the Global Pain Scale (GPS), however these may not be sufficiently sensitive to accurately detect improvements, especially at upper limb level; electromyography (EMG) may be the answer to this clinical requirement. The aim of this study was to quantify th...

objectives: this study was designed to determine the effects of volar-dorsal wrist/hand immobilization splint on upper extremity motor components and function of stroke patients. methods: fourteen patients were participated in this study. the patients were selected based on the inclusion and exclusion criteria, and were given the splint after a primary evaluation. they were re-evaluated after o...

OBJECTIVES This article provides an overview of the Upper Limb International Spasticity (ULIS) programme, which aims to develop a common core dataset for evaluation of real-life practice and outcomes in the treatment of upper-limb spasticity with botulinum toxin A (BoNT-A). Here we present the study protocol for ULIS-II, a large, international cohort study, to describe the rationale and steps t...

Background: Spasticity is one of the problems after a stroke. Due to this increase in muscle tone, patients are confronted with problems in motor control and difficulties in activities of daily living and complications such as shortness and contracture. The aim of this study was to examine the effects of the simultaneous use of both splint and botulinum toxin-A (BTX-A) injection on spasticity, ...

BACKGROUND Botulinum neurotoxin type A is a well-established treatment for a number of conditions involving muscle hyperactivity. Dysport (Ipsen Ltd, Wrexham, United Kingdom) is a botulinum neurotoxin type A preparation that has been available for a number of therapeutic uses for over 20 years in the European Union (EU). This survey was part of the EU botulinum toxin risk management plan to ide...

background: spasticity is one of the problems after a stroke. due to this increase in muscle tone, patients are confronted with problems in motor control and difficulties in activities of daily living and complications such as shortness and contracture. the aim of this study was to examine the effects of the simultaneous use of both splint and botulinum toxin-a (btx-a) injection on spasticity, ...

background: spasticity is one of the problems after a stroke. due to this increase in muscle tone, patients are confronted with problems in motor control and difficulties in activities of daily living and complications such as shortness and contracture. the aim of this study was to examine the effects of the simultaneous use of both splint and botulinum toxin-a (btx-a) injection on spasticity, ...